...
机译:一体化造血细胞移植的验证的小儿疾病风险指标
Emory Univ Sch Med Div Pediat Hematol Oncol Atlanta GA USA;
Med Coll Wisconsin Dept Med Ctr Int Blood &
Marrow Transplant Res Milwaukee WI 53226 USA;
Vanderbilt Univ Med Ctr Div Hematol Stem Cell Transplant Nashville TN USA;
Med Coll Wisconsin Dept Med Ctr Int Blood &
Marrow Transplant Res Milwaukee WI 53226 USA;
NCI Div Pediat Oncol Bethesda MD 20892 USA;
Univ Calif San Francisco Benioff Childrens Hosp Div Pediat Allergy Immunol &
Bone Marrow Transpla;
Sahlgrens Univ Hosp Dept Pediat Oncol Gothenburg Sweden;
Baylor Coll Med Dept Pediat Ctr Cell &
Gene Therapy Houston TX 77030 USA;
Univ Colorado Dept Pediat Div Canc &
Blood Disorders Aurora CO USA;
Duke Natl Univ Singapore NUS Med Sch Pediat Acad Clin Program Singapore Singapore;
Skane Univ Hosp Dept Pediat Sect Pediat Hematol Oncol Immunol &
Nephrol Lund Sweden;
Icahn Sch Med Mt Sinai Blood &
Marrow Transplant Program New York NY 10029 USA;
Univ Alabama Birmingham Div Hematol Oncol Birmingham AL 35294 USA;
Childrens Hosp Los Angeles Div Hematol Oncol Los Angeles CA 90027 USA;
Suny Downstate Med Ctr Dept Pediat Brooklyn NY 11203 USA;
St Jude Childrens Res Hosp Div Bone Marrow Transplantat 332 N Lauderdale St Memphis TN 38105 USA;
Univ British Columbia British Columbias Childrens Hosp Dept Pediat Hematol Oncol &
Bone Marrow;
Univ Michigan CS Mott Childrens Hosp Div Pediat Hematol Oncol Ann Arbor MI 48109 USA;
Med Coll Wisconsin Dept Med Ctr Int Blood &
Marrow Transplant Res Milwaukee WI 53226 USA;
机译:疾病风险指数是同种异体造血干细胞移植风险分层的可靠工具:一项针对欧洲血液和骨髓移植学会(EBMT)的大型队列的独立验证研究
机译:对恶性和非恶性疾病进行同种异体造血细胞移植的小儿和青少年患者早期移植后毒性的生存影响:认识到风险并优化结果
机译:同种异体造血干细胞移植后急性髓样白血病和骨髓增生异常综合征患者移植前血清铁蛋白评分系统和疾病风险的多中心验证
机译:同种异体造血细胞移植(HCT)中抑制杀伤细胞IG样受体(IKIR)匹配的影响
机译:与经历同种异体造血干细胞移植的青少年和青少年较差的预移植危险因素
机译:对恶性和非恶性疾病进行同种异体造血细胞移植的小儿和青少年患者早期移植后毒性的生存影响:认识风险并优化结果
机译:T细胞衰竭后接受异基因造血干细胞移植的患者预后的疾病风险指数验证
机译:未来研究需要在儿科人群中造血干细胞移植。从比较效力评论第48号中确定未来的研究需求